151 related articles for article (PubMed ID: 37950154)
1. A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results.
Zhang Y; Zhang W; Du H; Qu X; Chen Y; Wang J; Wu R
BMC Infect Dis; 2023 Nov; 23(1):783. PubMed ID: 37950154
[TBL] [Abstract][Full Text] [Related]
2. Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.
Zhang Y; Du H; Xiao A; Zhang W; Wang C; Huang X; Qu X; Wang J; Wu R
Infect Agent Cancer; 2022 Jun; 17(1):27. PubMed ID: 35690793
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening.
Yang Q; Du H; Qu X; Dai W; Gui L; Li C; Wang C; Guo C; Zhang Y; Wei L; Belinson JL; Wu R
Front Public Health; 2022; 10():1010066. PubMed ID: 36438219
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
6. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
[No Abstract] [Full Text] [Related]
7. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
8. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
Volesky KD; Magnan S; Mayrand MH; Isidean SD; El-Zein M; Comète E; Franco EL; Coutlée F
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):851-857. PubMed ID: 35131879
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
10. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
11. AmpFire HPV and ScreenFire RS HPV validation trial.
Hou J; Belinson JL; Du H; Li C; Zhang W; Zhang L; Zhang Y; Qu X; Wu R
Am J Clin Pathol; 2024 Jun; 161(6):535-542. PubMed ID: 38365314
[TBL] [Abstract][Full Text] [Related]
12. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
[TBL] [Abstract][Full Text] [Related]
13. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
[No Abstract] [Full Text] [Related]
14. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
Ebisch RM; de Kuyper-de Ridder GM; Bosgraaf RP; Massuger LF; IntHout J; Verhoef VM; Heideman DA; Snijders PJ; Meijer CJ; van Kemenade FJ; Bulten J; Siebers AG; Bekkers RL; Melchers WJ
Int J Cancer; 2016 Aug; 139(3):691-9. PubMed ID: 26991464
[TBL] [Abstract][Full Text] [Related]
15. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
Hanley SJB; Fujita H; Aoyama-Kikawa S; Kasamo M; Torigoe T; Matsuno Y; Noriaki S;
J Gynecol Oncol; 2021 Nov; 32(6):e86. PubMed ID: 34708593
[TBL] [Abstract][Full Text] [Related]
18. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
[TBL] [Abstract][Full Text] [Related]
19. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
20. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
